Molecular biology of basal and squamous cell carcinomas

Area of Science:

• Oncology
• Dermatology
• Molecular Biology

Background:

• Basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) are the most prevalent human skin cancers.
• Their incidence is projected to double in the next two decades, highlighting an urgent need for effective interventions.
• Understanding the molecular underpinnings of these cancers is crucial for developing targeted therapies and prevention strategies.

Purpose of the Study:

• To review recent advancements in understanding the molecular mechanisms of BCC and SCC.
• To discuss the clinical implications of these molecular discoveries.
• To highlight the potential for novel therapeutic and preventive strategies based on molecular insights.

Main Methods:

• Literature review of recent research on BCC and SCC molecular biology.
• Analysis of key molecular signaling pathways involved in skin cancer development.
• Synthesis of findings to connect molecular events with clinical outcomes.

Main Results:

• Identification of critical molecular events driving BCC and SCC.
• Highlighting the role of hedgehog signaling pathway activation in BCC, leading to targeted therapy opportunities.
• Summarizing progress in understanding the molecular landscape of SCC.

Conclusions:

• Molecular insights are transforming the approach to BCC and SCC treatment and prevention.
• Targeted therapies based on molecular pathways offer promising avenues for managing these common cancers.
• Continued research into the molecular biology of skin cancers is essential for future clinical advancements.